Clinical Trial Update: Trial of Indomethacin Prophylaxis in Preterm Infants (TIPP) [Phase 3]

View source ↗

Summary

Phase 3 trial of Indomethacin prophylaxis in preterm, very low birth weight infants (TIPP) has completed, evaluating prevention of patent ductus arteriosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Patent Ductus Arteriosus
• Premature Birth

Drugs mentioned

• INDOCIN (INDOMETHACIN)

Snippet

Sponsor: NICHD Neonatal Research Network | Conditions: Infant, Very Low Birth Weight, Infant, Premature | Phase 3 | Status: COMPLETED